Home/Filings/4/0001323212-26-000006
4//SEC Filing

Pauwels Eric 4

Accession 0001323212-26-000006

CIK 0001070081other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 5:20 PM ET

Size

13.0 KB

Accession

0001323212-26-000006

Insider Transaction Report

Form 4
Period: 2026-01-08
Pauwels Eric
CHIEF BUSINESS OFFICER
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-01-08$76.42/sh2,561$195,71284,928 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-08$76.98/sh587$45,18784,341 total
  • Sale

    Common Stock

    [F4]
    2026-01-08$76.45/sh1,454$111,15882,887 total
  • Sale

    Common Stock

    [F1][F5]
    2026-01-09$77.41/sh1,722$133,30081,165 total
  • Sale

    Common Stock

    [F1][F6]
    2026-01-12$78.70/sh1,024$80,58980,141 total
Footnotes (6)
  • [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.
  • [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.89 to $76.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.91 to $77.13 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 4,200 RSUs from a January 7, 2022 grant of 16,800 RSUs.
  • [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.10 to $77.77 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.16 to $79.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact|2026-01-12

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001323212

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:20 PM ET
Size
13.0 KB